FDA Approves Preservative-Free Xelpros™ for Open-Angle Glaucoma
FDA Approves preservative-free XELPROS™ (latanoprost ophthalmic emulsion 0.005%) for intraocular pressure (IOP) reduction in patients with open-angle glaucoma and ocular hypertension
PolyActiva Commences Clinical Trial of Biodegradable Ocular Implant for Glaucoma
Clinical Trial Begins For PolyActiva Biodegradable Glaucoma Implant. PolyActiva Pty Ltd, a clinical-stage Australian biotechnology company, has recently received USD$12million in venture capital to fund its Phase 1 Clinical Trial which will evaluate the safety and tolerability of its PA5108 ocular implant designed to biodegrade after the treatment period.
MicroInvasive Glaucoma Surgery (MIGS) Where To Next?
Iqbal Ike K. Ahmed, MD, FRCSC, asks surgeons to comment on what excites them about the future of minimally invasive glaucoma surgery (MIGS). Mark J. Gallardo, MD; Nathan M. Radcliffe, MD; I. Paul Singh, MD; Mahmoud A. Khaimi, MD; and David Richardson, MD, discuss MIGS devices in the pipeline and explain how these procedures improve the quality of life for both patients and physicians.
Ab Interno Canaloplasty (ABiC™) In The Spotlight
Iqbal Ike K. Ahmed, MD, FRCSC, asks a group of experts featuring Mark J. Gallardo, MD; Nathan M. Radcliffe, MD; Mahmoud A. Khaimi, MD; David Richardson, MD; and I. Paul Singh, MD, to address the misconceptions and barriers to adoption for ab interno canaloplasty (ABiC). The group explains how ABiC iTrack (Ellex) compares to other minimally invasive glaucoma surgery (MIGS) procedures.
MicroInvasive Glaucoma Surgery (MIGS) In Daily Practice
Iqbal Ike K. Ahmed, MD, FRCSC, opens up discussion on preferred minimally invasive glaucoma surgery (MIGS) procedures. Mark J. Gallardo, MD; I. Paul Singh, MD; Mahmoud A. Khaimi, MD; David Richardson, MD; and Nathan M. Radcliffe, MD, each describe their approach to MIGS and discuss the mechanism of action of ABiC iTrack (Ellex).
Misconceptions About Selective Laser Trabeculoplasty (SLT)
Iqbal Ike K. Ahmed, MD, FRCSC, Nathan M. Radcliffe, MD; I. Paul Singh, MD; Mahmoud A. Khaimi, MD; Mark J. Gallardo, MD; and David Richardson, MD, discuss the the misconceptions surrounding selective laser trabeculoplasty (SLT), safety and efficacy of SLT and highlight the advantages of minimizing the medication burden for patients.
Interventional Glaucoma: SLT AND MIGS
At ASCRS 2018 in Washington, DC, a group of surgeons experienced in interventional glaucoma therapies sat down to discuss the roles of selective laser trabeculoplasty (SLT) and microinvasive glaucoma surgery (MIGS) for treatment of open angle glaucoma (OAG).
